VAERS Explorer
Back to explore

Report #2847387

Received Jun 26, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
MT
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (1)

Occupational exposure to product

Symptom narrative

nurses at the healthcare facility was drawing up a shingrix vaccine (after the antigen and adjuvant were mixed); Accidental exposure to product; drop sprayed in her eye; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of occupational exposure while preparing product for administration in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On 16-JUN-2025, an unknown time after receiving Shingrix, the patient experienced occupational exposure while preparing product for administration (Verbatim: nurses at the healthcare facility was drawing up a shingrix vaccine (after the antigen and adjuvant were mixed)), inadvertent exposure to vaccine (Verbatim: Accidental exposure to product) and exposure via eye contact (Verbatim: drop sprayed in her eye). The outcome of the occupational exposure while preparing product for administration, inadvertent exposure to vaccine and exposure via eye contact were not applicable. Additional Information: GSK Receipt Date: 16-JUN-2025 Pharmacist reported that one of the nurses at the healthcare facility was drawing up a Shingrix vaccine (after the antigen and adjuvant were mixed) and a drop sprayed in her eye which led to inadvertent exposure to vaccine (Adverse event -Accidental Exposure).